Skip to main content

Table 3 Current medication among the groups

From: Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus

Medications NGR (Group I) (n = 1170) IGR (Group II) (n = 389) DM (Group III) (n = 343)
Antihypertensive drugs    
Diuretic (%) 0 (0.0) 0 (0.0) 0 (0.0)
ARB (%) 77 (6.6) 25 (6.4) 46 (13.4)
ACEI (%) 27 (2.3) 16 (4.1) 23 (6.7)
β-blocker (%) 12 (1.0) 10 (2.6) 5 (1.5)
CCB (%) 86 (7.4) 53 (13.6) 59 (17.2)
Others (%) 36 (3.1) 24 (6.2) 10 (2.9)
Antidiabetic drugs    Self-reported T2DM
(n = 178)
Insulin (%)    31 (17.4)
Oral hypoglycemic drugs    
Metformin (%)    61 (34.3)
Sulphonylurea (%)    41 (23.0)
Glinide (%)    26 (14.6)
Thiazolidinedione (%)    10 (5.6)
α-Glucosidase inhibitor (%)    24 (13.5)
Others (%)    3 (1.7)
  1. Descriptive values are expressed as frequency (%).
  2. Abbreviations: ARB Angiotensin II receptor blocker, ACEI Angiotensin-converting enzyme inhibitor, CCB Calcium channel blocker.